Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cholinergic receptor muscarinic M1 (CHRM1) is a G protein-coupled receptor that binds acetylcholine. It is predominantly expressed in the central nervous system, exocrine glands, and gastric tissue. It plays a crucial role in cognitive processes such as learning and memory, neuronal excitability, and glandular secretion. Dysregulation of M1 receptor signaling has been implicated in cognitive disorders and autoimmune conditions. Antagonists can cause side effects such as dry mouth and confusion.
Agonism or antagonism of M1 receptor, modulating downstream signaling pathways such as PLC/IP3/DAG and calcium mobilization
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cholinergic receptor muscarinic M1 (CHRM1).